Inicio>>Signaling Pathways>> GPCR/G protein>> S1P receptor inhibitor>>Sphingosine-1-phosphate

Sphingosine-1-phosphate (Synonyms: Sphingosine-1-phosphate (d18:1); S1P (d18:1); Sphingosine-1-Phosphoric Acid)

Catalog No.GC17004

La esfingosina 1-fosfato es un producto metabólico de los esfingolípidos de la membrana celular.

Products are for research use only. Not for human use. We do not sell to patients.

Sphingosine-1-phosphate Chemical Structure

Cas No.: 26993-30-6

Tamaño Precio Disponibilidad Cantidad
1mg
131,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 2 publications

Product Documents

Quality Control & SDS

View current batch:

Background

El esfingosina 1-fosfato es un producto metabólico de los esfingolípidos de la membrana celular. Está unido a chaperonas extracelulares, enriquecido en fluidos circulatorios y se une a receptores acoplados a proteínas G del esfingosina 1-fosfato (Sphingosine 1-phosphateRs) utilizados para regular el desarrollo embrionario, la función de órganos postnatales y enfermedades.[1]

In vitro, el tratamiento con 200 y 400 μM de esfingosina-1-fosfato en muestras corticales ováricas humanas disminuyó de manera dependiente de la dosis la expresión proteica de caspasa-3 clivada mediante western blot y el número de folículos apoptóticos teñidos positivamente para caspasa-3 clivada mediante inmunohistoquímica. Además, in vitro, con una concentración dependiente del Sphingosine 1-phosphate entre 0.1-10 μM se evocó la generación potencial (AP) por grabaciones electrofisiológicas de fibra única. Además, utilizando experimentos de imagen Ca2+, Sphingosine 1-phosphate a 1 μM puede provocar un aumento transitorio en el Ca2+ intracelular en los astrocitos seguido por una elevación sostenida.

En vivo, la superfusión de 0.001-10 μM de esfingosina 1-fosfato provocó una vasoconstricción dependiente de la concentración en microvasos preglomerulares, predominantemente arteriolas aferentes. En un experimento in vivo se demostró que la inyección intravenosa de 10 mg/kg de esfingosina 1-fosfato en ratones causó rigidez e muerte inmediata. En beagles machos, el tratamiento con 85 ug/kg de esfingosina 1-fosfato por vía intravenosa disminuyó la formación del cociente Q(s)/Q(t) (32%), y tanto la presencia de proteínas (72%) como los neutrófilos (95%) en el líquido BAL en comparación con los controles tratados con vehículo. Sin embargo, la esfingosina 1-fostato aumentó la producción sistémica inducida por LPS de tres citocinas inflamatorias: TNF-alfa (6 veces), KC (1,2 veces) e IL-6 (3 veces), sin resultar en disfunción endorgánica.

References:
[1]Cartier A, et al. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science. 2019 Oct 18;366(6463):eaar5551.
[2]Guzel Y, et al. Sphingosine-1-phosphate protects human ovarian follicles from apoptosis in vitro. Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:19-24.
[3]Patil MJ, et al. Sphingosine-1-phosphate activates mouse vagal airway afferent C-fibres via Sphingosine 1-phosphateR3 receptors. J Physiol. 2019 Apr;597(7):2007-2019.
[4]Shirakawa H, et al. Sphingosine-1-phosphate induces Ca2+ signaling and CXCL1 release via TRPC6 channel in astrocytes. Glia. 2017 Jun;65(6):1005-1016.
[5]Guan Z, et al. Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature. J Am Soc Nephrol. 2014 Aug;25(8):1774-85.
[6]Igarashi Y, et al. Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles. Acta Biochim Pol. 1998;45(2):299-309.
[7]Szczepaniak WS,et al. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. Transl Res. 2008 Nov;152(5):213-24.

Chemical Properties

Cas No. 26993-30-6 SDF
Sinónimos Sphingosine-1-phosphate (d18:1); S1P (d18:1); Sphingosine-1-Phosphoric Acid
Chemical Name (2S,3R,E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate
Canonical SMILES O[C@H](/C=C/CCCCCCCCCCCCC)[C@H](COP(O)(O)=O)N
Formula C18H38NO5P M.Wt 379.5
Solubility ≤4 mg/ml in 0.3M NaOH Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.635 mL 13.1752 mL 26.3505 mL
5 mM 0.527 mL 2.635 mL 5.2701 mL
10 mM 0.2635 mL 1.3175 mL 2.635 mL
  • Molarity Calculator

  • Dilution Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Related Video

    Sphingosine-1-phosphate-GlpBio

Reseñas

Review for Sphingosine-1-phosphate

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sphingosine-1-phosphate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.